First Derm

JULY 2, 2024

Online Dermatologist Sweating and Eczema: How to Manage Flare-Ups Eczema and Sweat | Symptoms of eczema | Physiology | How Sweating Affects Eczema | Triggers for Eczema | Related conditions | Managing Sweat to Prevent Eczema Flare-Ups | Treatment Key Takeaways Eczema, particularly atopic dermatitis, flares up with triggers like sweat.

Eczema 45

Eczema Management Dermatitis Irritation 45

Kim Gallo Esthetics

APRIL 10, 2023

Skin conditions Additionally, certain skin conditions such as rosacea, eczema, and psoriasis can cause skin redness and irritation. Jade rollers, cold therapy masks, and other tools can also be used to soothe the skin. It is therefore important to recognize the underlying cause of the irritation to treat it accordingly.

Irritation 195

Irritation Moisturization Rosacea Skincare Routine 195

The Dermatology Digest

JANUARY 13, 2025

Rezpegaldesleukin is a first-in-class interleukin-2 receptor (IL-2R) agonist that proliferates and activates regulatory T cells (Tregs) with promising dose-dependent clinical activity in multiple skin disease settings. Robin, President and CEO of Nektar Therapeutics, in a news release.

Dermatitis 36

Dermatitis Clinic Eczema Therapy 36

The Dermatology Digest

MARCH 9, 2024

Chronic hand eczema (CHE) symptoms can take a dramatic toll on patients’ quality of life. Mark Lebwohl, MD, Dean for Clinical Therapeutics and Waldman Professor and Chairman of the Kimberly and Eric J. Watch Now [the_ad id="7336"] The post Chronic Hand Eczema 101 appeared first on The Dermatology Digest.

Eczema 36

Eczema Dermatitis Dermatology Clinic 36

Aesthetics Advisor

MARCH 10, 2024

Infants of mothers randomized to cut out eggs, milk, and fish were significantly less likely to have eczema even years later. Eczema, also known as atopic dermatitis, is a chronic inflammatory skin disease. Steroids are the first-line therapy, but then there are immunosuppressants as well, with more in the drug pipeline.

Eczema 36

Eczema Diet Dermatitis Document 36

The Dermatology Digest

DECEMBER 13, 2024

Food and Drug Administration (FDA) has approved nemolizumab (Nemluvio, Galderma) for the treatment of patients aged 12 and older with moderate to severe atopic dermatitis, in combination with topical corticosteroids (TCS) and/or calcineurin inhibitors (TCI) when the disease is not adequately controlled with topical prescription therapies.

Dermatitis 69

Dermatitis Safety Eczema Dermatology 69

The Dermatology Digest

FEBRUARY 14, 2024

This follows its designation as a Breakthrough Therapy for the treatment of pruritus associated with prurigo nodularis, originally granted in December 2019 and reconfirmed in March 2023. In the ARCADIA program, nemolizumab clinically improved skin lesions and rapidly improved itch and sleep disturbance.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

The Dermatology Digest

MARCH 11, 2024

Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best. Mark Lebwohl, MD, Dean for Clinical Therapeutics and Waldman Professor and Chairman of the Kimberly and Eric J.

Dermatitis 69

Dermatitis Eczema Dermatology Pharmaceutical 69

The Dermatology Digest

SEPTEMBER 8, 2024

Distraction Techniques for Medical Procedures In addition to or in lieu of pharmacologic pain relievers, various psychological approaches have demonstrated effectiveness in alleviating pain and discomfort, including cognitive-behavioral therapy, hypnosis, and distraction. Felemban OM, Alshamrani RM, Aljeddawi DH, et al. BMC Oral Health.

Technology 74

Technology Dermatology Injections Medical 74

The Dermatology Digest

JUNE 14, 2024

The late-breaking data, presented at the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference in Chicago, Illinois, showed that upadacitinib bested dupilumab for all ranked secondary endpoints of LEVEL-UP, including complete skin clearance and rapid resolution of itching in patients with severe itch.

Dermatitis 36

Dermatitis Eczema Therapy Clinic 36

The Dermatology Digest

DECEMBER 14, 2023

ALM) and etherna are teaming up to discover and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. Etherna and Almirall will work collaboratively on the research activities, while Almirall will lead clinical development and commercialization. Almirall, S.A.

Medical 36

Medical Therapy Dermatology Sales 36

The Dermatology Digest

DECEMBER 19, 2023

Aldeyra Therapeutics’ investigational RASP modulator ADX-629 performed well in a Phase 2 clinical trial of patients with atopic dermatitis (AD), according to topline results. The open-label, single-center Phase 2 clinical trial of ADX-629 included eight mild-to-moderate AD patients.

Dermatitis 36

Dermatitis Eczema Clinic Therapy 36

The Dermatology Digest

DECEMBER 18, 2023

Air pollution may contribute to the development or worsening of skin conditions such as atopic dermatitis and eczema, according to researchers out of Massachusetts General Hospital (MGH).

Eczema 36

Eczema Dermatitis Hospital Dermatology 36

The Dermatology Digest

DECEMBER 15, 2023

Food and Drug Administration (FDA) has expanded the approval of tralokinumab-ldrm (Adbry, LEO Pharma Inc) to include kids aged 12-17 years with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.

Eczema 36

Eczema Dermatitis Safety Therapy 36

The Dermatology Digest

DECEMBER 15, 2023

Food and Drug Administration (FDA) has expanded the approval of tralokinumab-ldrm (Adbry, LEO Pharma Inc) to include kids aged 12-17 years with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.

Eczema 36

Eczema Dermatitis Safety Therapy 36

First Derm

JUNE 10, 2024

Dermatitis, also known as eczema is a jumbled area in dermatology. Dermatitis makes up 20% of all new patients referred to dermatology clinics. [1] 1] The word eczema originates from the Greek word of ‘boiling’, reflecting the early appearance in the disease. [2] Avoiding triggers is also important.

Dermatitis 45

Dermatitis Irritation Eczema Dry Skin 45

Lipgloss and Aftershave

FEBRUARY 28, 2024

You’ll want to learn how LED Light Therapy can work on skin, body, and hair in your practice! We also have the inside scoop on a post-clinical treatment tool that your patients will thank you for! LED Light Therapy For Skin, Body + Hair, from Celluma LED Light Therapy Literally, an LED Light Therapy device for every client.

Technology 52

Technology Medical Skincare Chemical Peels 52

Lipgloss and Aftershave

SEPTEMBER 5, 2023

We’re big fans of Celluma for professional-level LED light therapy. If you want unlimited modality options for your treatment room – you must have the Universal Derma-Duo from DermaJEM ; it will provide hydrodermabrasion, oxygen infusion, cold therapy and so much more! Professional-grade, clinically proven.

Tools 52

Tools Microdermabrasion Chemical Peels Facials 52

The Dermatology Digest

DECEMBER 14, 2023

ALM) and etherna are teaming up to discover and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. Etherna and Almirall will work collaboratively on the research activities, while Almirall will lead clinical development and commercialization. Almirall, S.A.

Medical 28

Medical Therapy Dermatology Sales 28

The Dermatology Digest

MARCH 28, 2024

The blood test measures RNA gene expression to predicts flares before they happen and provides specific information about a patient’s disease abnormalities, allowing physicians to make evidence-based decisions regarding therapy.

Treatments 36

Treatments Hospital Management Eczema 36

The Dermatology Digest

FEBRUARY 1, 2024

Atopy patch tests (APTs) may be the best way to detect food‐triggered atopic dermatitis (AD), according to a new literature review in Clinical Reviews in Allergy & Immunology. APTs detect sensitization to food proteins responsible for systemic contact dermatitis (SCD), which can then be confirmed by oral food challenge.

Dermatitis 36

Dermatitis Eczema Medical Therapy 36

The Dermatology Digest

MARCH 10, 2024

Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, shares pearls on keeping pediatric patients comfortable during common dermatologic procedures. From distraction techniques to pharmacologic measures, Peter A.

Dermatology 36

Dermatology Dermatitis Eczema Clinic 36

The Dermatology Digest

MARCH 9, 2024

Mark Lebwohl, MD, Dean for Clinical Therapeutics and Waldman Professor and Chairman of the Kimberly and Eric J. Mark Lebwohl, MD, Dean for Clinical Therapeutics and Waldman Professor and Chairman of the Kimberly and Eric J. The biosimilars are here with even more coming down the pike.

Dermatology 36

Dermatology Dermatitis Eczema Clinic 36

The Dermatology Digest

MARCH 9, 2024

Mark Lebwohl, MD, Dean for Clinical Therapeutics and Waldman Professor and Chairman of the Kimberly and Eric J. Watch Now Chronic Hand Eczema 101 Jonathan Silverberg, MD, PhD, MPH Chronic hand eczema (CHE) symptoms can take a dramatic toll on patients’ quality of life. Watch Now Biosimilars in Dermatology: Where Do They Fit in?

Dermatitis 36

Dermatitis Eczema Dermatology Clinic 36

The Dermatology Digest

MARCH 9, 2024

Mark Lebwohl, MD, Dean for Clinical Therapeutics and Waldman Professor and Chairman of the Kimberly and Eric J. Watch Now Chronic Hand Eczema 101 Jonathan Silverberg, MD, PhD, MPH Chronic hand eczema (CHE) symptoms can take a dramatic toll on patients’ quality of life. Watch Now Biosimilars in Dermatology: Where Do They Fit in?

Dermatitis 36

Dermatitis Eczema Dermatology Clinic 36

The Dermatology Digest

MARCH 9, 2024

Mark Lebwohl, MD, Dean for Clinical Therapeutics and Waldman Professor and Chairman of the Kimberly and Eric J. Watch Now Chronic Hand Eczema 101 Jonathan Silverberg, MD, PhD, MPH Chronic hand eczema (CHE) symptoms can take a dramatic toll on patients’ quality of life. Watch Now Biosimilars in Dermatology: Where Do They Fit in?

Dermatitis 36

Dermatitis Eczema Dermatology Clinic 36

US Dermatologt Partners

APRIL 15, 2025

Certified by the American Board of Dermatology and a Fellow of the American Academy of Dermatology, Dr. Watchmaker evaluates and treats skin conditions such as acne, skin cancer, scarring, hair loss, psoriasis, eczema, and rashes. While there, she was assigned to follow a dermatologist.

Dermatology 36

Dermatology Scarring Medical Skin Issues 36

The Dermatology Digest

OCTOBER 26, 2024

Level Up is a phase 3b/4 global, randomized, open-label, efficacy assessor-blinded, head-to-head, multi-center study evaluating upadacitinib vs. dupilumab in adolescents and adults with moderate-to-severe AD who had an inadequate response to systemic therapy or when the use of those therapies was inadvisable. In the switchers, 47.6%

Dermatitis 36

Dermatitis Treatments Pharmaceutical Eczema 36

US Dermatologt Partners

SEPTEMBER 5, 2023

Dr. Baltazar began his career in healthcare with a Doctorate in Physical Therapy from the University of the Pacific in Stockton, California. Dr. Baltazar is currently accepting patients for conditions such as acne, psoriasis, eczema, and skin cancer. To learn more, visit usdermatologypartners.com.

Dermatology 36

Dermatology Office Eczema Networking 36

First Derm

MARCH 8, 2023

Skin-related causes include athlete’s foot, eczema, psoriasis, contact dermatitis, scabies, and fungal infections. Eczema can affect various parts of the body, including the feet. Eczema can affect various parts of the body, including the feet. In severe cases, eczema can cause painful cracks and blisters.

Eczema 52

Eczema Dermatitis Medical Dry Skin 52

The Dermatology Digest

DECEMBER 15, 2023

Food and Drug Administration (FDA) has expanded the approval of tralokinumab-ldrm (Adbry, LEO Pharma Inc) to include kids aged 12-17 years with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.

Eczema 28

Eczema Dermatitis Safety Therapy 28

The Dermatology Digest

MAY 6, 2024

The Phase 2a trial ( NCT05984784 ) evaluates the safety, pharmacokinetics, and efficacy of IMG-007 in adult patients with moderate-to-severe AD who had inadequate response to and/or intolerant of topical therapies. Key study endpoints include safety and percent change from baseline in eczema area and severity index (EASI) over time.

Safety 36

Safety Therapy Dermatitis Eczema 36

The Dermatology Digest

MARCH 11, 2024

Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best. Mark Lebwohl, MD, Dean for Clinical Therapeutics and Waldman Professor and Chairman of the Kimberly and Eric J.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 11, 2024

Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best. Mark Lebwohl, MD, Dean for Clinical Therapeutics and Waldman Professor and Chairman of the Kimberly and Eric J.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 11, 2024

Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best. Mark Lebwohl, MD, Dean for Clinical Therapeutics and Waldman Professor and Chairman of the Kimberly and Eric J.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 10, 2024

Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best. Mark Lebwohl, MD, Dean for Clinical Therapeutics and Waldman Professor and Chairman of the Kimberly and Eric J.

Treatments 36

Treatments Dermatitis Eczema Dermatology 36

The Dermatology Digest

MARCH 10, 2024

Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best. Mark Lebwohl, MD, Dean for Clinical Therapeutics and Waldman Professor and Chairman of the Kimberly and Eric J.

Treatments 36

Treatments Pharmaceutical Dermatitis Eczema 36